These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12561919)

  • 21. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations.
    Seah SK
    J Trop Med Hyg; 1975 Jul; 78(7):150-3. PubMed ID: 1177347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxoplasma gondii: fluconazole and itraconazole activity against toxoplasmosis in a murine model.
    Martins-Duarte ES; Lemgruber L; de Souza W; Vommaro RC
    Exp Parasitol; 2010 Apr; 124(4):466-9. PubMed ID: 20045696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
    Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H
    J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
    Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A
    Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rifabutin is active in murine models of toxoplasmosis.
    Araujo FG; Slifer T; Remington JS
    Antimicrob Agents Chemother; 1994 Mar; 38(3):570-5. PubMed ID: 8203856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
    Alder J; Hutch T; Meulbroek JA; Clement JC
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
    Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM
    Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
    Araujo FG; Suzuki Y; Remington JS
    Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):394-7. PubMed ID: 8793398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro effect of combined traditional Chinese medicine (Changqing capsule) on the tachyzoites of Toxoplasma gondii].
    Zhang W; Fang FR; Liu YJ; Yang LD; Luo RY; Gong F; Lu H; Xu XX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):56-8. PubMed ID: 16866146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental study of the activity of the sulphamethoxypyrazine (Longum equals Kelfizina) with pyrimethamine (Daraprim) on the cysts development phase of Toxoplasma gondii in Mastomys natalensis. Further contribution to experimental chemotherapy of toxoplasmosis (author's transl)].
    Werner H; Egger I
    Zentralbl Bakteriol Orig A; 1974 Jun; 226(4):554-60. PubMed ID: 4152678
    [No Abstract]   [Full Text] [Related]  

  • 34. Two 2-hydroxy-3-alkyl-1,4-naphthoquinones with in vitro and in vivo activities against Toxoplasma gondii.
    Khan AA; Nasr M; Araujo FG
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2284-9. PubMed ID: 9736550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study.
    Reiter-Owona I; Hlobil H; Enders M; Klarmann-Schulz U; Gruetzmacher B; Rilling V; Hoerauf A; Garweg JG
    Eur J Med Res; 2020 Nov; 25(1):59. PubMed ID: 33228795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
    Derouin F; Almadany R; Chau F; Rouveix B; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrimethamine-loaded lipid-core nanocapsules to improve drug efficacy for the treatment of toxoplasmosis.
    Pissinate K; dos Santos Martins-Duarte É; Schaffazick SR; de Oliveira CP; Vommaro RC; Guterres SS; Pohlmann AR; de Souza W
    Parasitol Res; 2014 Feb; 113(2):555-64. PubMed ID: 24292545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis.
    Schöler N; Krause K; Kayser O; Müller RH; Borner K; Hahn H; Liesenfeld O
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1771-9. PubMed ID: 11353624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
    Martinez A; Allegra CJ; Kovacs JA
    Am J Trop Med Hyg; 1996 Mar; 54(3):249-52. PubMed ID: 8600759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis.
    Khan AA; Slifer T; Araujo FG; Polzer RJ; Remington JS
    Antimicrob Agents Chemother; 1997 May; 41(5):893-7. PubMed ID: 9145840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.